John R Fowler1, Kevin Byrne2, Tiffany Pan3, Robert J Goitz2. 1. Department of Orthopaedics, University of Pittsburgh, Pittsburgh, PA. Electronic address: Johnfowler10@gmail.com. 2. Department of Orthopaedics, University of Pittsburgh, Pittsburgh, PA. 3. First State Orthopaedics, Newark, DE.
Abstract
PURPOSE: The purpose of the study was to determine the rate of false positives for nerve conduction studies (NCSs) and ultrasound (US) in a population without signs and symptoms of carpal tunnel syndrome (CTS) using a CTS-6 score of 0 as the reference standard. METHODS: Patients were included in this study if they were referred for NCSs for a reason other than CTS (cubital tunnel syndrome and/or cervical radiculopathy) and they had a CTS-6 score of 0. An US measurement of the cross-sectional area (CSA) of the median nerve at the level of the carpal tunnel inlet was performed by a certified ultrasound technician. An a priori CSA cutoff of 10 mm2 or greater measured using US at the carpal tunnel inlet qualified as a positive diagnosis. The NCSs were performed and interpreted according to national standards by a certified electrodiagnostician. All patients in this study were considered to not have a diagnosis of CTS based on the CTS-6 of 0. RESULTS: Forty hands with a CTS-6 of 0 were included in this study. The US was positive in 9 of 40(23%) and NCS was positive in 17 of 40 (43%). There were only 2 patients with a false-positive US that did not also have a positive NCS. However, there were 11 patients who had a false-positive NCS that did not have a positive US. CONCLUSIONS: This prospective cohort series has demonstrated that US has a lower false-positive rate than NCSs in asymptomatic patients as measured by the CTS-6 diagnostic tool. Studies with a low false-positive rate are preferred when ordering a confirmatory diagnostic test. Therefore, if a confirmatory diagnostic test is desired, we recommend that US be used rather than NCSs. TYPE OF STUDY/LEVEL OF EVIDENCE: Diagnostic II.
PURPOSE: The purpose of the study was to determine the rate of false positives for nerve conduction studies (NCSs) and ultrasound (US) in a population without signs and symptoms of carpal tunnel syndrome (CTS) using a CTS-6 score of 0 as the reference standard. METHODS:Patients were included in this study if they were referred for NCSs for a reason other than CTS (cubital tunnel syndrome and/or cervical radiculopathy) and they had a CTS-6 score of 0. An US measurement of the cross-sectional area (CSA) of the median nerve at the level of the carpal tunnel inlet was performed by a certified ultrasound technician. An a priori CSA cutoff of 10 mm2 or greater measured using US at the carpal tunnel inlet qualified as a positive diagnosis. The NCSs were performed and interpreted according to national standards by a certified electrodiagnostician. All patients in this study were considered to not have a diagnosis of CTS based on the CTS-6 of 0. RESULTS: Forty hands with a CTS-6 of 0 were included in this study. The US was positive in 9 of 40(23%) and NCS was positive in 17 of 40 (43%). There were only 2 patients with a false-positive US that did not also have a positive NCS. However, there were 11 patients who had a false-positive NCS that did not have a positive US. CONCLUSIONS: This prospective cohort series has demonstrated that US has a lower false-positive rate than NCSs in asymptomatic patients as measured by the CTS-6 diagnostic tool. Studies with a low false-positive rate are preferred when ordering a confirmatory diagnostic test. Therefore, if a confirmatory diagnostic test is desired, we recommend that US be used rather than NCSs. TYPE OF STUDY/LEVEL OF EVIDENCE: Diagnostic II.
Authors: Carlos Henrique Fernandes; João Baptista Gomes Dos Santos; Francisco Schwartz-Fernandes; A Lee Ostermann; Flávio Faloppa Journal: Rev Bras Ortop (Sao Paulo) Date: 2020-09-22
Authors: Pierre R Bourque; John Brooks; Theo Mobach; Brendan Gammon; Steven Papp; Jodi Warman-Chardon Journal: PLoS One Date: 2020-04-13 Impact factor: 3.240